China Pharma Holdings (CPHI) Cash from Investing Activities Growth (1y) (2011 - 2025)
China Pharma Holdings (CPHI) Cash from Investing Activities Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -308.05% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -41.51% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -139.86% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 129.18% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 1.71% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -366.90% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -96.43% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | China Pharma Holdings | 41.34 Mn | 41.03 Mn | 83,566.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 97.89% |
| Sep 30, 2025 | -540.33% |
| Dec 31, 2024 | -5,927.21% |
| Sep 30, 2024 | 113.67% |
| Dec 31, 2023 | -116.60% |
| Sep 30, 2023 | 73.29% |
| Jun 30, 2023 | 102.57% |
| Mar 31, 2023 | 4,123.29% |
| Dec 31, 2022 | 486.45% |
| Sep 30, 2022 | 39.29% |
| Dec 31, 2021 | -103.03% |
| Sep 30, 2021 | -60.34% |
| Dec 31, 2020 | 562.70% |
| Sep 30, 2020 | -2,026.29% |
| Jun 30, 2020 | -150,299.39% |
| Mar 31, 2020 | -370.85% |
| Dec 31, 2019 | -182.18% |
| Sep 30, 2019 | -264.21% |
| Jun 30, 2019 | 101.24% |
| Mar 31, 2019 | -1,936.56% |